Document is current
Any future updates will be listed below
-
Authors
Dingli, David
Rizio, Avery A.
Broderick, Lynne
LaGasse, Kaitlin
Rucker, Sloan
Carty, Michelle K.
Burton, Elise
Gordon, Shaquilla
Yen, Glorian P.
Paulose, Jincy
Geevarghese, Anumaxine
Lee, Soyon
-
Funding
Funding for this research was provided by:
Novartis Pharma AG
- License Information
-
More Information
Article History
Received: 15 May 2024
Accepted: 5 November 2024
First Online: 18 November 2024
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by an independent Institutional Review Board (Western Institutional Review Board-Copernicus Group [WCG], #20230839).
: Informed consent was obtained from all individual participants included in the study.
: GPY, JP, AG, and SL are employees of Novartis Pharmaceuticals Corporation; GPY and SL also own stock in the company. SG and EB have received consultancy funding and honoraria from Novartis. DD has received consultancy and research funding from Novartis. AAR, LB, KL, SR, and MKC are employees of QualityMetric, an IQVIA business, and received funding from Novartis to conduct this research.
